Why Summit Therapeutics Rocketed 584% in 2024 | The Motley Fool

1 day ago · Summit Therapeutics' drug Ivonescimab posted positive results in not one but two phase 3 trials during 2024. It also received "fast track" status from the FDA. Despite its …

584%
OFF

Why Summit Therapeutics Rocketed 584% In 2024 | The Motley Fool

2 weeks from now

1 day ago · Summit Therapeutics' drug Ivonescimab posted positive results in not one but two phase 3 trials during 2024. It also received "fast track" status from the FDA. Despite its …

fool.com

584%
OFF

Why Summit Therapeutics Rocketed 584% In 2024 - Yahoo Finance

2 weeks from now

21 hours ago · Why Summit Therapeutics Rocketed 584% in 2024. Billy Duberstein, The Motley Fool . Wed, Jan 15, 2025, 6:35 AM 3 min read. In This Article: SMMT .

yahoo.com

15%
OFF

Where Will Summit Therapeutics Be In 5 Years? | The Motley Fool

2 weeks from now

Dec 20, 2024 · Summit Therapeutics (SMMT-5.15%) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab, a potential cancer treatment. …

fool.com

60%
OFF

Why Summit Therapeutics Rocketed Over 60% Today - Yahoo …

2 weeks from now

Sep 9, 2024 · Billy Duberstein, The Motley Fool . Mon, Sep 9, 2024, 2:01 PM 3 min read. In This Article: SMMT . Shares of Summit Therapeutics (NASDAQ: SMMT) rocketed as high as 75.2% …

yahoo.com

600%
OFF

Up Over 600% In 2024, Can Summit Therapeutics Stock Keep Rising?

2 weeks from now

Oct 24, 2024 · Cory Renauer, The Motley Fool . Thu, Oct 24, 2024, 5:13 AM 5 min read. In This Article: SMMT . To say this has been a big year for Summit Therapeutics (NASDAQ: ...

yahoo.com

584%
OFF

Why Summit Therapeutics Rocketed 584% In 2024 - MSN

2 weeks from now

The Motley Fool has positions in and recommends Summit Therapeutics. The Motley Fool has a disclosure policy. Why Summit Therapeutics Rocketed 584% in 2024 ...

msn.com

6%
OFF

Why Summit Therapeutics Stock Rocketed 6% Higher On Friday

2 weeks from now

Dec 6, 2024 · Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More Why Summit …

fool.com

60%
OFF

Why Summit Therapeutics Rocketed Over 60% Today - MSN

2 weeks from now

Sep 9, 2024 · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Summit Therapeutics wasn’t one of them. The …

msn.com

6%
OFF

Why Summit Therapeutics Stock Rocketed 6% Higher On Friday

2 weeks from now

Dec 7, 2024 · Eric Volkman, The Motley Fool December 6, 2024 at 7:09 PM Summit Therapeutics (NASDAQ: SMMT) stock got a real shot in the arm Friday with the initiation of coverage by a …

aol.com

6%
OFF

Why Summit Therapeutics Stock Rocketed 6% Higher On Friday

2 weeks from now

Dec 7, 2024 · Why Summit Therapeutics Stock Rocketed 6% Higher on Friday. Eric Volkman, The Motley Fool . Fri, Dec 6, 2024, 7:09 PM 2 min read. In This Article: SMMT .

yahoo.com

600%
OFF

Up Over 600% In 2024, Can Summit Therapeutics Stock Keep …

2 weeks from now

Summit recently completed enrollment of a phase 3 trial with second-line lung cancer patients based in the U.S. If adding ivonescimab to standard chemotherapy improves patients' odds of …

msn.com

600%
OFF

Up Over 600% In 2024, Can Summit Therapeutics Stock Keep Rising?

2 weeks from now

Oct 24, 2024 · To say this has been a big year for Summit Therapeutics (SMMT 1.60%) would be a huge understatement. The stock has risen over 600% since the end of 2023, thanks to …

fool.com

72%
OFF

3 Stocks That Could Be Monster Winners In 2025 | The Motley Fool

2 weeks from now

Dec 29, 2024 · Here's why they believe Novo Nordisk (NVO 0.72%), Summit Therapeutics (SMMT-5.15%), and Viking Therapeutics (VKTX-3.18%) could be monster winners for 2025. …

fool.com

63%
OFF

Is Summit Therapeutics A Millionaire Maker? | The Motley Fool

2 weeks from now

Oct 27, 2024 · Still, shares of Summit Therapeutics (SMMT 3.63%) are up by more than 989% in the last 12 months as I write this, and that's reason enough for investors to wonder if it might …

fool.com

$5000
OFF

Summit Therapeutics Inc. (SMMT) - Yahoo Finance

2 weeks from now

Motley Fool • 28 days ago Investing $5,000 in Each of These 3 Stocks at the Start of 2024 Would Have Created a Portfolio Worth More Than $100,000 Today Motley Fool • 29 days ago

yahoo.com

FAQs about Why Summit Therapeutics Rocketed 584% in 2024 | The Motley Fool Coupon?

What happened to Summit Therapeutics (SMMT)?

Shares of Summit Therapeutics (SMMT 16.49%) rocketed as high as 75.2% Monday, before settling into a 57.5% gain as of 1:27 PM EDT. The biotech firm released the results of a Phase III study on Sunday at the 2024 World Conference on Lung Cancer in San Diego. ...

Will Summit Therapeutics make significant progress in the next 5 years?

Summit Therapeutics should make significant progress in the next five years. Summit Therapeutics (SMMT -0.60%) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab, a potential cancer treatment. The company's shares are up by 340% since January 2023. The market has high hopes for the biotech. ...

Is Summit Therapeutics (SMMT) a good stock to buy in 2024?

Summit Therapeutics' drug Ivonescimab posted positive results in not one but two phase 3 trials during 2024. It also received "fast track" status from the FDA. Despite its massive 2024 gains, analysts remain bullish. Shares of biotech Summit Therapeutics (SMMT 9.31%) skyrocketed 583.7% in 2024, according to data from S&P Global Market Intelligence. ...

Can Summit Therapeutics stock keep rising in 2024?

Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising? T o say this has been a big year for Summit Therapeutics(NASDAQ: SMMT) would be a huge understatement. The stock has risen over 600% since the end of 2023, thanks to surprisingly positive trial results for a cancer therapy called ivonescimab. ...

Will 2024 be a good year for Summit Therapeutics?

Keith Speights (Summit Therapeutics): 2024 has been a fantastic year for Summit Therapeutics, with its stock delivering an explosive 7x gain. I think the new year will bring more good fortune for this up-and-coming drugmaker. ...

Why did Summit Therapeutics stock shoot higher this September?

Summit Therapeutics stock shot higher this September in response to outstanding clinical-trial results. The company's lead candidate is a cancer therapy that's already approved in China. Summit's market valuation implies a great deal of success that's a long way from guaranteed. ...